Orphan Designation: Hydroxy-Propyl-Beta-Cyclodextrin, Treatment of Niemann-Pick Disease, Type C

Case Medical Research
doi 10.31525/cmr-da7a89
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Endogenous and Synthetic Neurosteroids in Treatment of Niemann–Pick Type C Disease

Brain Research Reviews
2008English

Cyclodextrin Triggers McOLN1-dependent Endo-Lysosome Secretion in Niemann-Pick Type C Cells

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2019English

Characterization of Hydroxypropyl-Beta-Cyclodextrins Used in the Treatment of Niemann-Pick Disease Type C1

PLoS ONE
Multidisciplinary
2017English

The Spectrum of Niemann-Pick Type C Disease in Greece

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2017English

Correction: Characterization of Hydroxypropyl-Beta-Cyclodextrins Used in the Treatment of Niemann-Pick Disease Type C1

PLoS ONE
Multidisciplinary
2018English

Niemann-Pick Disease

Turkish Journal of Haematology
Hematology
2011English

Niemann-Pick Disease, Type C1 (NPC1)

Science-Business eXchange
2008English

Niemann–Pick Type C Pathogenesis and Treatment: From Statins to Sugars

Clinical Lipidology
2010English

Niemann-Pick Type C Disease: Molecular Mechanisms and Potential Therapeutic Approaches

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy